Feeding regulation by ASB4
ASB4 的饲喂调节
基本信息
- 批准号:10886884
- 负责人:
- 金额:$ 16.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:ART proteinAcuteAmino Acid SequenceAnimalsAnkyrin RepeatAppetite DepressantsAreaAttenuatedBindingBinge EatingBody WeightBrainCalcitoninCalcitonin ReceptorCellsCephalicConsumptionDown-RegulationEatingEvolutionFastingFeeding PatternsFoodFood deprivation (experimental)Gene TargetingGenesGeneticGoalsHealthHumanHyperphagiaHypothalamic structureIRS4 geneInjectionsIntermittent fastingLeptinLeptin deficiencyLigandsLinkMediatingMetabolicMetabolic ControlMetabolic hormoneMetabolismMusNeuronsNon-Insulin-Dependent Diabetes MellitusNutritional statusObesityOpsinPersonsPhenotypePhotophobiaPlayProsencephalonProtein DeficiencyRegulationResistanceRoleSalmonSatiationStructure of nucleus infundibularis hypothalamiSurveysWeight maintenance regimencell typecognitive functioncopingenergy balancefeedinggene environment interactiongenetic variantgenome wide association studyhindbrainimprovedinsightknock-downnovelobesity developmentoptogeneticssexubiquitin-protein ligase
项目摘要
Project Summary/Abstract
The genetic basis of most common forms of obesity is polygenic, highlighting the importance of interactions
among different genetic variants in body weight regulation. Indeed, large-scale GWAS studies have identified
increasing number of genetic variants that are associated with human obesity. Despite these advances, the
metabolic functions of these genetic variants and how they interact with key regulators of energy balance are
still poorly understood. We recently identified Ankyrin Repeat and SOCS Box Containing 4 (ASB4), a gene that
is linked to human obesity by multiple GWAS studies, as an important regulator of satiety especially after
period of food deprivation. Expression of Asb4 is modulated by nutritional status, being responsive to leptin
and agouti-related protein in a reciprocal fashion, allowing ASB4 to sense changes of body’s energy reserve.
We show that ASB4 deficiency leads to increased meal size and food intake during periods of intense feeding,
such as refeeding. We also show that ASB4 is required for the expression of calcitonin receptor (CalcR) and
the anorectic effects of salmon calcitonin, a potent ligand for CalcR. Together, these findings strongly indicate
that ASB4 is important for metabolic control in humans and mice, and that it is an important regulator of meal
size. The goal of this R01 application is to determine the mechanisms by which ASB4 exerts its metabolic
effects. We will identify ASB4 neuronal subpopulations that control meal size and food intake. We will evaluate
if importance of ASB4 in satiety control manifests under intermittent fasting, a feeding pattern that promotes
consumption of large meals. As ASB4 is highly conserved between mice and humans and is linked to obesity
by GWAS studies, this study will provide mechanistic insight into how ASB4 may regulate meal size and food
intake in humans.
项目摘要/摘要
大多数常见肥胖症的遗传基础是多基因的,突出了相互作用的重要性
在体重调节的不同遗传变异中。事实上,大规模的全球气候变化研究已经确定
越来越多的与人类肥胖有关的基因变异。尽管有这些进步,但
这些遗传变异的代谢功能以及它们如何与能量平衡的关键调节因子相互作用
人们对此仍知之甚少。我们最近发现了Ankyrin Repeat和SoCS Box包含4(ASB4),一个可以
被多项GWAS研究表明与人类肥胖有关,作为饱腹感的重要调节因素,尤其是在
食物匮乏的时期。Asb4的表达受营养状态的调节,对瘦素有反应
和刺鼠相关蛋白的相互作用,使ASB4能够感知人体能量储备的变化。
我们发现,缺乏ASB4会导致紧张喂食期间的食量和食物摄入量增加,
比如重新进食。我们还发现,ASB4是降钙素受体(CalcR)表达所必需的,并且
鲑鱼降钙素,一种有效的钙调蛋白配体的厌食作用。总而言之,这些发现强烈表明
ASB4对人类和小鼠的新陈代谢控制很重要,它是膳食的重要调节剂
尺码。此R01应用程序的目标是确定ASB4发挥其代谢作用的机制
效果。我们将确定控制进食量和食物摄入量的ASB4神经元亚群。我们将评估
如果ASB4在控制饱腹感方面的重要性在间歇禁食下表现出来,一种促进
大餐的消费。因为ASB4在老鼠和人类之间高度保守,并与肥胖有关
通过GWAS的研究,这项研究将提供ASB4如何调节膳食大小和食物的机械性洞察
人体摄入量。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Allison W Xu其他文献
Allison W Xu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Allison W Xu', 18)}}的其他基金
Blood-hypothalamus barrier and metabolic impairment in advanced aging
老年时的血液-下丘脑屏障和代谢损伤
- 批准号:
10548160 - 财政年份:2019
- 资助金额:
$ 16.15万 - 项目类别:
Blood-hypothalamus barrier and metabolic impairment in advanced aging
老年时的血液-下丘脑屏障和代谢损伤
- 批准号:
9764178 - 财政年份:2019
- 资助金额:
$ 16.15万 - 项目类别:
Blood-hypothalamus barrier and metabolic impairment in advanced aging
老年时的血液-下丘脑屏障和代谢损伤
- 批准号:
9897509 - 财政年份:2019
- 资助金额:
$ 16.15万 - 项目类别:
Blood-hypothalamus barrier and metabolic impairment in advanced aging
老年时的血液-下丘脑屏障和代谢损伤
- 批准号:
10343683 - 财政年份:2019
- 资助金额:
$ 16.15万 - 项目类别:
A brain-liver circuit in regulation of alcoholic liver disease
调节酒精性肝病的脑-肝回路
- 批准号:
8913876 - 财政年份:2014
- 资助金额:
$ 16.15万 - 项目类别:
A brain-liver circuit in regulation of alcoholic liver disease
调节酒精性肝病的脑-肝回路
- 批准号:
9302619 - 财政年份:2014
- 资助金额:
$ 16.15万 - 项目类别:
A brain-liver circuit in regulation of alcoholic liver disease
调节酒精性肝病的脑-肝回路
- 批准号:
8761674 - 财政年份:2014
- 资助金额:
$ 16.15万 - 项目类别:
Compensatory Regulation of Energy Balance by Neurogenesis in Adult Hypothalamus
成人下丘脑神经发生对能量平衡的代偿性调节
- 批准号:
8451524 - 财政年份:2010
- 资助金额:
$ 16.15万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 16.15万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 16.15万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 16.15万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 16.15万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 16.15万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 16.15万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 16.15万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 16.15万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 16.15万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 16.15万 - 项目类别:
Standard Grant














{{item.name}}会员




